Alcon revenue rises 10 percent missing analyst estimates
Alcon posted 2.69 billion dollars in revenue, missing estimates as implantables sales stalled. The firm raised its full-year guidance and plans a share buyback.
Xurve View
Insights:
Xurve View
ALCON INC reported a 10% revenue increase to $2.69 billion in the first quarter of 2026. Net sales missed the $2.71 billion estimate set by LSEG analysts as implantable segment growth stalled. The miss highlights investor concerns about competitive pressures offsetting new product momentum.
